The FDA just expanded a landmark gene therapy to children as young as 2. Here's what Casgevy actually does, and why the age expansion matters.
Jul 12, 2026
•
5 min read
The first person to receive stem cell therapy for Huntington's disease was treated last month. Here is exactly what we know, and what we don't.
Jul 3, 2026
A 12-person Chicago trial just put every participant off insulin. What that result means, what it doesn't, and why it matters to stem cell therapy.
Jun 19, 2026
Stem cells do not operate independently. They live in microenvironments that tell them what to do. Those environments communicate largely in peptides, and understanding that conversation changes how the field thinks about treatment.
Jun 9, 2026
